RH Bophelo Limited
Incorporated in the Republic of South Africa
(Registration number: 2016/533398/06)
JSE share code: RHB, ISIN: ZAE000244737
(“RHB” or “the Company”)
The Company is in the process of finalising its half year results for the interim period ended 31
August 2018, which are scheduled to be released on or about 16 November 2018.
Shareholders are advised that the Company expects to report earnings per share and headline
per share of between 58 to 66 cents, being an increase of between 43% and 63%, compared to
prior interim period of 40,7 cents.
The increase in earnings in the current year period were mainly attributable to the increase in
interest income of R9 225 272 to R15 832 157 (prior year period: R 6 606 885) and an increase in
the fair value valuation of RHB’s investee companies of R29 985 263 (prior year period: Nil). The
Company acquired African Healthcare (“AHC”), Vryburg Private Hospital (“VPH”) on 26 April 2018
and Rondebosch Medical Centre Proprietary Limited (“RMC”) on 14 May 2018.
The above is based on the weighted average number of shares (“W ANOS”) in issue during the
current period ended 31 August 2018 of 50 821 918 (prior year period: 13 858 696). The Company
issued 49,999,999 ordinary shares on 12 July 2017 upon its listing on the JSE, with a subsequent
issue of new shares of 1,250,000 on 26 April 2018. Shares issued in the current period were only
included in the calculation of W ANOS for only 120 days. The total number of shares in issue as at
31 August 2018 was 51 250 000.
The financial information on which this trading statement has been based has neither been
reviewed nor reported on by the Company’s external auditors.
15 November 2018
Sponsor: Deloitte & Touche Sponsor Services Proprietary Limited
Date: 15/11/2018 09:18:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Email this JSE Sens Item to a Friend.